FBI internal travel request for interview of Jeffrey Epstein-related minors (07/24/2006 investigation)Is Invitation: No
1 duplicate copy in the archive
Bob Hugin’s Celgene background highlighted in campaign materials
Title Matchkaggle-ho-028415
Case Filed-24448House OversightBob Hugin’s Celgene background highlighted in campaign materials
November 11, 20252p1 persons
Case File
d-24448House OversightBob Hugin’s Celgene background highlighted in campaign materials
Other
The passage merely outlines Hugin’s career at Celgene and his political candidacy, with no specific allegations, financial transactions, or novel connections to misconduct. It provides background cont Bob Hugin was CEO and later executive chairman of Celgene before running for U.S. Senate in New Jers Celgene’s flagship drug Revlimid generated $8.2 billion in 2017 sales. Hugin’s campaign references
Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #028415
Pages
2
Persons
1
Integrity
No Hash Available
Loading document viewer...
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.